(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Carlsmed's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast CARL's revenue for 2025 to be $1,211,568,088, with the lowest CARL revenue forecast at $1,205,454,427, and the highest CARL revenue forecast at $1,217,681,749. On average, 2 Wall Street analysts forecast CARL's revenue for 2026 to be $1,727,906,616, with the lowest CARL revenue forecast at $1,684,180,650, and the highest CARL revenue forecast at $1,771,632,581.
In 2027, CARL is forecast to generate $2,538,631,203 in revenue, with the lowest revenue forecast at $2,452,375,423 and the highest revenue forecast at $2,624,886,983.